Track the CF PharmTech, Inc. stock price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Operating in the Health Care sector, CF PharmTech, Inc. has recorded 1 insider filings. Market capitalisation: €7.1bn. The latest transaction was reported on 9 April 2026 (Purchase). Among the most active insiders: BOVET LI LI. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
CF PharmTech, Inc. 是一家在香港证券交易所上市的医疗保健和制药领域的公司。它专注于创新医药产品的开发和制造。